Pharmalab — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Pharmalab is a US-based contract development and manufacturing organization (CDMO) serving the OTC drug, dietary supplement, and cosmetic sectors. Its core business is providing end-to-end manufacturing services, from formulation to packaging, leveraging its FDA-registered facility and NSF GMP certifications to ensure quality and compliance. The company operates as a private entity, focusing on building durable partnerships with brands seeking reliable, scalable production for liquid and semi-solid products. Its market position is defined by regulatory expertise, a flexible service model, and a commitment to competitive pricing within the contract manufacturing landscape.

Drug DeliveryMedical Devices

Technology Platform

FDA-registered and NSF GMP-certified manufacturing platform for liquid and semi-solid dosage forms, providing full turn-key contract development and manufacturing services (CDMO).

Opportunities

Growth in the OTC drug and dietary supplement markets, coupled with a strong trend toward outsourcing manufacturing, provides a steady demand for Pharmalab's services.

Its specialized focus on liquid and semi-solid formulations and its NSF GMP certifications serve as key differentiators to attract brands seeking high-quality, compliant manufacturing partners.

Risk Factors

Key risks include regulatory compliance failures, which could jeopardize its certifications and client trust, and intense competition in the CDMO space that could pressure pricing and margins.

The company is also exposed to supply chain disruptions for raw materials and economic downturns affecting consumer spending on non-essential health products.

Competitive Landscape

Pharmalab competes in the fragmented contract manufacturing industry for OTC drugs and supplements, facing competition from other small-to-mid-sized CDMOs as well as large, diversified manufacturers. Its competitive edge is based on its specific expertise in liquids/semi-solids and its NSF certifications, but it must continually demonstrate value against rivals competing on cost, capacity, or broader service offerings.

More companies in Small Molecule Drugs →More companies in United States →